Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

NCT06543966 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

486

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-operative Nausea and Vomiting (PONV)

Interventions

DRUG: Aprepitant Injection
DRUG: Aprepitant Injection Placebo

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.